Perkinelmer (PKI)
NYSE:PKI

PerkinElmer (PKI) Stock Price & Analysis

453 Followers

PKI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$113.34 - $190.18
Previous Close$139.5
Volume569.87K
Average Volume (3M)792.44K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$400.74M
Total Debt (Recent Filing)$4.54B
Price to Earnings (P/E)29.2
Beta0.98
Next EarningsFeb 14, 2023
Dividend Yield0.28 (0.2%)
EPS (TTM)4.78
Shares Outstanding126,315,920
R-Squared0.46
Standard Deviation0.09
10 Day Avg. Volume736,696
30 Day Avg. Volume792,437
Price to Book (P/B)-6.41
Price to Sales (P/S)6.84
Price to Cash Flow (P/CF)19.90
P/FCF Ratio38.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside14.57% Upside
Rating ConsensusModerate Buy
Alpha0.00468
Number of Analyst Covering11


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PKI FAQ

What was PerkinElmer’s price range in the past 12 months?
PerkinElmer lowest stock price was $113.34 and its highest was $190.18 in the past 12 months.
    What is PerkinElmer’s market cap?
    Currently, no data Available
    When is PerkinElmer’s upcoming earnings report date?
    PerkinElmer’s upcoming earnings report date is Feb 14, 2023 which is in 6 days.
      How were PerkinElmer’s earnings last quarter?
      PerkinElmer released its earnings results on Nov 08, 2022. The company reported $1.51 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.07.
        Is PerkinElmer overvalued?
        According to Wall Street analysts PerkinElmer’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does PerkinElmer pay dividends?
          PerkinElmer pays a Quarterly dividend of $0.07 which represents an annual dividend yield of 0.2%. See more information on PerkinElmer dividends here
            What is PerkinElmer’s EPS estimate?
            PerkinElmer’s EPS estimate is $1.64.
              How many shares outstanding does PerkinElmer have?
              PerkinElmer has 126,315,920 shares outstanding.
                What happened to PerkinElmer’s price movement after its last earnings report?
                PerkinElmer reported an EPS of $1.51 in its last earnings report, beating expectations of $1.44. Following the earnings report the stock price went down -1.626%.
                  Which hedge fund is a major shareholder of PerkinElmer?
                  Among the largest hedge funds holding PerkinElmer’s share is PRIMECAP Management Co. It holds PerkinElmer’s shares valued at 155M.

                    ---

                    PerkinElmer Stock Smart Score

                    8
                    Outperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    The PerkinElmer stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Perkinelmer

                    PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Agilent
                    IQVIA Holdings
                    Illumina
                    Mettler-Toledo
                    Waters

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis